These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 11289114

  • 1. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull VS, Williams JH, Ingley E, Schneider-Mergener J, Krystal G, Klinken SP.
    Cancer Res; 2001 Mar 15; 61(6):2453-8. PubMed ID: 11289114
    [Abstract] [Full Text] [Related]

  • 2. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Handoko A, Singer P, Stone L, McCarthy DJ, Klinken SP, Hibbs ML, Ingley E.
    Biochem J; 2014 May 01; 459(3):455-66. PubMed ID: 24552351
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells.
    Tilbrook PA, Bittorf T, Callus BA, Busfield SJ, Ingley E, Klinken SP.
    Cell Growth Differ; 1996 Apr 01; 7(4):511-20. PubMed ID: 9052992
    [Abstract] [Full Text] [Related]

  • 4. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S, Ichikawa H, Okada T, Sarai A, Sugimoto T, Morimoto H, Kihara T, Yano A, Nakao K, Nagake Y, Wada J, Makino H.
    J Am Soc Nephrol; 2004 Dec 01; 15(12):3215-24. PubMed ID: 15579525
    [Abstract] [Full Text] [Related]

  • 5. Dominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivo.
    Cull V, Tilbrook PA, Adenan AS, Chappell D, Ingley E, Sarna MK, Palmer TN, Watowich SS, Klinken SP.
    Oncogene; 2000 Feb 17; 19(7):953-60. PubMed ID: 10702804
    [Abstract] [Full Text] [Related]

  • 6. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Feb 17; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 7. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells.
    Tilbrook PA, Ingley E, Williams JH, Hibbs ML, Klinken SP.
    EMBO J; 1997 Apr 01; 16(7):1610-9. PubMed ID: 9130706
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin-stimulated Raf-1 tyrosine phosphorylation is associated with the tyrosine kinase Lyn in J2E erythroleukemic cells.
    Tilbrook PA, Colley SM, McCarthy DJ, Marais R, Klinken SP.
    Arch Biochem Biophys; 2001 Dec 01; 396(1):128-32. PubMed ID: 11716471
    [Abstract] [Full Text] [Related]

  • 9. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H, Chida D, Damen JE, Krystal G, Miyajima A.
    Biochem Biophys Res Commun; 1997 May 08; 234(1):198-205. PubMed ID: 9168989
    [Abstract] [Full Text] [Related]

  • 10. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J.
    Oncogene; 2001 Oct 04; 20(45):6643-50. PubMed ID: 11641791
    [Abstract] [Full Text] [Related]

  • 11. Activated Fps/Fes tyrosine kinase regulates erythroid differentiation and survival.
    Sangrar W, Gao Y, Bates B, Zirngibl R, Greer PA.
    Exp Hematol; 2004 Oct 04; 32(10):935-45. PubMed ID: 15504549
    [Abstract] [Full Text] [Related]

  • 12. HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells.
    Ingley E, Sarna MK, Beaumont JG, Tilbrook PA, Tsai S, Takemoto Y, Williams JH, Klinken SP.
    J Biol Chem; 2000 Mar 17; 275(11):7887-93. PubMed ID: 10713104
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
    Yamashita T, Wakao H, Miyajima A, Asano S.
    Cancer Res; 1998 Feb 01; 58(3):556-61. PubMed ID: 9458105
    [Abstract] [Full Text] [Related]

  • 16. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL, Pelus LM, Lord KA.
    Stem Cells; 2000 Feb 01; 18(5):366-73. PubMed ID: 11007921
    [Abstract] [Full Text] [Related]

  • 17. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM, Hawley TS, Hawley RG, Qu CK.
    Oncogene; 2003 Sep 04; 22(38):5995-6004. PubMed ID: 12955078
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S, Varlet P, Verdier F, Gobert S, Cartron JP, Gisselbrecht S, Mayeux P, Lacombe C.
    EMBO J; 1996 Aug 15; 15(16):4174-81. PubMed ID: 8861946
    [Abstract] [Full Text] [Related]

  • 20. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF.
    Reese TT, Gregory RC, Sharlow ER, Pacifici RE, Crouse JA, Todokoro K, Wojchowski DM.
    Growth Factors; 1997 Aug 15; 14(2-3):161-76. PubMed ID: 9255607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.